The level of galectin-3 in the blood serum of patients with chronic hepatitis C

The level of galectin-3 in the blood serum of patients with chronic hepatitis C

Aim. to assess galectin-3 level in the serum of HCV patients according to the biochemical activity of hepatitis, liver fibrosis, in view of insulin resistance and overweight.Materials and methods: The content of serum galectin-3 was detected in 78 patients with chronic hepatitis C in age from 20 to...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Kovalevа, N. S. Zhevnerova, T. V. Antonova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2016-07-01
Series:	Журнал инфектологии
Subjects:	chronic hepatitis c galectin-3 liver fibrosis insulin resistance metabolic syndrome
Online Access:	https://journal.niidi.ru/jofin/article/view/484
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

LIPID METABOLISM DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS C
by: L. I. Tkachenko, et al.
Published: (2015-12-01)

Lipid and carbohydrate metabolism disturbances in children with chronic hepatitis C
by: A. O. Nikiforova, et al.
Published: (2024-09-01)

Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)

Leptin and Adiponectin Levels in Patients with Chronic Hepatitis C with Carbohydrate and Lipid Metabolism Disorders
by: T. V. Antonova, et al.
Published: (2014-10-01)

GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Serum Elabela Level as a Reliable Biomarker for Predicting of Liver Fibrosis in Iraqi Patients with Chronic Hepatitis C
by: Eham Amer Ali, et al.
Published: (2024-07-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Adiponectin level and severity of liver fibrosis in patients chronic hepatitis C with metabolic syndrome
by: A. F. Novikova, et al.
Published: (2018-07-01)

Comorbidity and multimorbidity in patients with chronic hepatitis C
by: Ya. E. Saranskaya, et al.
Published: (2022-10-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

The Role of Cystatin C and Galectin-3 in Cardiorenal Syndrome
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01)

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
by: L. M. Syzova, et al.
Published: (2019-06-01)

Galectin-3 in the blood serum of patients with bone tumors
by: N. E. Kushlinskii, et al.
Published: (2023-07-01)

Сhronic hepatitis C in patients with мetabolic syndrome
by: T. V. Antonova, et al.
Published: (2014-09-01)

GALECTIN-3 LEVEL IN pATIENTS WITH mETAbOLIC SYNDROmE AND CORONARY HEART DISEASE
by: O. М. Drapkina, et al.
Published: (2017-03-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

Assessment of liver fibrosis stage influence on clinical course of periodontal diseases in patients with chronic hepatitis C
by: О. М. Slaba, et al.
Published: (2017-08-01)

Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling
by: Ting Zeng, et al.
Published: (2025-02-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Non-invasive diagnosis of fibrosis in patients with CHC and obesity
by: K. V. Zhdanov, et al.
Published: (2020-03-01)

THE COURSE OF HEPATITIS C INFECTION AND RESPONSE TO ANTI-VIRAL THERAPY IN PATIENTS WITH THALASSEMIA MAJOR AND HEPATITIS C INFECTION: A LONGITUDINAL, PROSPECTIVE STUDY.
by: Sanaa Kamal, et al.
Published: (2019-10-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

FIB-4 and APRI scores for predicting severe fibrosis in chronic hepatitis C - a developing country's perspective in DAA era
by: Uros Karic, et al.
Published: (2018-03-01)

The importance of single-nucleotide gene polymorphisms in the formation of liver cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C
by: I. V. Mannanova, et al.
Published: (2024-06-01)

Effect of a garlic drench on Galectin gene expression in ovine whole blood
by: SreeNavya Inupala, et al.
Published: (2024-12-01)

Serum insulin-like growth factor binding protein 2 is associated with hepatic steatosis in adults with metabolic dysfunction-associated steatotic liver disease
by: Ziwei Wang, et al.
Published: (2025-07-01)

Features of chronic hepatitis C in a patient with metabolic syndrome (clinical case)
by: A. A. Koklyushkina, et al.
Published: (2024-09-01)

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 MEASUREMENT IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE
by: O. M. Drapkina, et al.
Published: (2015-10-01)

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature
by: Olga H. Orasan, et al.
Published: (2019-10-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Association of Liver Histology with Serum ALT Levels in Patients with Chronic Hepatitis C
by: Wajeeha Ahad, et al.
Published: (2017-06-01)

Diagnostic value of galectin-3 in heart transplant recipients with myocardial complications
by: O. P. Shevchenko, et al.
Published: (2020-04-01)